Amid escalating corona cases in GHMC area, Telangana government today started clinical trials using Covaxin, a vaccine to prevent virus spread, manufactured by Bharath Biotech Company.
Nizam’s Institute of Medical Research (NIMS) Hospital officials have started the clinical trials process by using the Covaxin. The vaccine will be used in three stages on healthy persons to find its functioning and results.
NIMS Hospital officials stated that the registration of healthy persons started upon their agreement for the clinical trials. The doctors will conduct several tests on them before commencing the clinical trials.
They chose right persons who cooperate for the same after collecting blood samples. The first dose will be administered on the persons after a week they said. The doctors also informed that they will observe the persons for two days after the first dose.
NIMS Director Manohar said that they will give second dose of Covaxin to them after 14 days.